Cardio Diagnostics Holdings Stock Analysis
| CDIOW Stock | USD 0.04 0.01 20.49% |
Cardio Diagnostics Holdings is overvalued with Real Value of 0.0314 and Hype Value of 0.03. The main objective of Cardio Diagnostics stock analysis is to determine its intrinsic value, which is an estimate of what Cardio Diagnostics Holdings is worth, separate from its market price. There are two main types of Cardio Diagnostics' stock analysis: fundamental analysis and technical analysis.
The Cardio Diagnostics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Cardio Diagnostics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Cardio Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. Cardio Stock Analysis Notes
The company had not issued any dividends in recent years. Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of cardiovascular disease. Cardio Diagnostics Inc. was founded in 2017 and is based in Chicago, Illinois. Cardio Diagnostics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on Cardio Diagnostics Holdings please contact Meeshanthini Dogan at 855 226 9991 or go to https://cdio.ai.Cardio Diagnostics Investment Alerts
| Cardio Diagnostics generated a negative expected return over the last 90 days | |
| Cardio Diagnostics has high historical volatility and very poor performance | |
| Cardio Diagnostics has some characteristics of a very speculative penny stock | |
| Cardio Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 34.89 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 34.89 K. | |
| Cardio Diagnostics generates negative cash flow from operations | |
| Cardio Diagnostics has a frail financial position based on the latest SEC disclosures |
Cardio Diagnostics Thematic Classifications
In addition to having Cardio Diagnostics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
Technical Drivers
As of the 23rd of April, Cardio Diagnostics shows the Standard Deviation of 17.19, mean deviation of 12.18, and Risk Adjusted Performance of 0.0076. Cardio Diagnostics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cardio Diagnostics information ratio and kurtosis to decide if Cardio Diagnostics is priced correctly, providing market reflects its regular price of 0.0394 per share. As Cardio Diagnostics appears to be a penny stock we also recommend to validate its jensen alpha numbers.Cardio Diagnostics Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Weighted Moving Average calculates a weight for each value in Cardio Diagnostics price series with the more recent values given greater weights.
Cardio Diagnostics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardio Diagnostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardio Diagnostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardio Diagnostics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Timur Dogan over a month ago Acquisition by Timur Dogan of 157750 shares of Cardio Diagnostics at 1.26 subject to Rule 16b-3 | ||
Burton Paul Frederick over a month ago Insider Trading | ||
Levy Oded over three months ago Disposition of tradable shares by Levy Oded of Cardio Diagnostics subject to Rule 16b-3 | ||
Philibert Robert over six months ago Acquisition by Philibert Robert of 16000 shares of Cardio Diagnostics at 0.6 subject to Rule 16b-3 | ||
Sim Brandon over six months ago Acquisition by Sim Brandon of tradable shares of Cardio Diagnostics subject to Rule 16b-3 |
Cardio Diagnostics Outstanding Bonds
Cardio Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cardio Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cardio bonds can be classified according to their maturity, which is the date when Cardio Diagnostics Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Cardio Diagnostics Predictive Daily Indicators
Cardio Diagnostics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cardio Diagnostics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 10.25 | |||
| Daily Balance Of Power | 67.0 | |||
| Rate Of Daily Change | 1.2 | |||
| Day Median Price | 0.0395 | |||
| Day Typical Price | 0.0394 | |||
| Price Action Indicator | 0.0033 | |||
| Period Momentum Indicator | 0.0067 |
Cardio Diagnostics Forecast Models
Cardio Diagnostics' time-series forecasting models are one of many Cardio Diagnostics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cardio Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Cardio Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cardio Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cardio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cardio Diagnostics. By using and applying Cardio Stock analysis, traders can create a robust methodology for identifying Cardio entry and exit points for their positions.
Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of cardiovascular disease. Cardio Diagnostics Inc. was founded in 2017 and is based in Chicago, Illinois. Cardio Diagnostics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cardio Diagnostics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.